These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7134486)

  • 1. Neuroendocrinological aspects of depression and symptomatological picture.
    Tosca P; Fenoglio L; Zerbi F; Romani A; Bezzi G; Ferrari E; Canepari C
    Psychiatr Clin (Basel); 1982; 15(3):153-9. PubMed ID: 7134486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum postdexamethasone prolactin measures in depressive patients and control subjects.
    Maes M; Schotte C; Peeters D; D'Hondt P; Martin M; Blockx P; Minner B; Suy E; Cosyns P
    J Psychiatr Res; 1991; 25(3):109-16. PubMed ID: 1941707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin response to dexamethasone: a study on normal controls and depressed patients.
    Rupprecht R; Barocka A; Jecht E; Noder M; Pichl J; Schwarz W
    Acta Psychiatr Scand; 1987 Aug; 76(2):139-43. PubMed ID: 3673636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postdexamethasone prolactin and cortisol: a biological state variable in depression.
    Klein HE; Seibold B; Bender W; Nedopil N; Albus M; Schmauss M
    Acta Psychiatr Scand; 1984 Sep; 70(3):239-47. PubMed ID: 6496148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal and post-dexamethasone cortisol and prolactin concentrations in depressed and non-depressed patients with chronic pain syndromes.
    Atkinson JH; Kremer EF; Risch SC; Janowsky DS
    Pain; 1986 Apr; 25(1):23-34. PubMed ID: 3714287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.
    Rubin RT; Poland RE; Lesser IM; Winston RA; Blodgett AL
    Arch Gen Psychiatry; 1987 Apr; 44(4):328-36. PubMed ID: 3566455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported diurnal mood changes, early morning awakening and the dexamethasone suppression test in endogenous depression.
    Grunhaus L; Flegel P; Carroll BJ; Greden JF
    J Affect Disord; 1985; 8(1):1-7. PubMed ID: 3156907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients.
    Meltzer HY; Fang VS; Tricou BJ; Robertson A; Piyaka SK
    Am J Psychiatry; 1982 Jun; 139(6):763-8. PubMed ID: 7081489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A relationship between prolactin levels and dexamethasone suppression test results in major depressive disorder.
    Joyce PR; Donald RA; Livesey JH
    J Affect Disord; 1985; 8(2):191-5. PubMed ID: 3157731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone.
    Arana GW; Reichlin S; Workman R; Haaser R; Shader RI
    Am J Psychiatry; 1988 Jun; 145(6):707-11. PubMed ID: 3369557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P; Smythe G; Parker G; Wilhelm K; Hickie I; Brodaty H; Boyce P
    Br J Psychiatry; 1990 Oct; 157():551-7. PubMed ID: 2131137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls.
    Holsboer F; Gerken A; Steiger A; Fass V
    Acta Psychiatr Scand; 1984 May; 69(5):383-90. PubMed ID: 6730994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol escape from suppression by dexamethasone during depression is strongly predicted by basal cortisol hypersecretion and increasing age combined.
    Maes M; Minner B; Suy E; D'Hondt P; Jacobs MP; Raus J
    Psychoneuroendocrinology; 1991; 16(4):295-310. PubMed ID: 1745698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal responses to fenfluramine in depressed and control subjects.
    Mitchell P; Smythe G
    J Affect Disord; 1990 May; 19(1):43-51. PubMed ID: 2140846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test in depression.
    Dam H; Mellerup ET; Rafaelsen OJ
    J Affect Disord; 1985; 8(1):95-103. PubMed ID: 3156917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of beta-endorphin, cortisol, prolactin and growth hormone in depressed patients.
    Galard R; Gallart J; Arguello JM; Schwartz S; Castellanos JM; Catalán R
    Acta Psychiatr Scand; 1988 Aug; 78(2):230-3. PubMed ID: 2975911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine responses in psychiatric and pain patients with major depression.
    Atkinson JH; Kremer EF; Risch SC; Dana R; Janowsky DS
    Biol Psychiatry; 1986 Jun; 21(7):612-20. PubMed ID: 3708035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morning and evening adrenocortical responses to ACTH stimulation in endogenously depressed patients: a preliminary report.
    Shimoda K; Yamada N; Hanada K; Tsujimoto T; Takahashi S; Takahashi K
    Jpn J Psychiatry Neurol; 1989 Mar; 43(1):57-62. PubMed ID: 2544755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
    Johnson GF; Hunt G; Kerr K; Caterson I
    Psychiatry Res; 1984 Dec; 13(4):305-13. PubMed ID: 6596587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.